The expression of BTG1 is downregulated in nasopharyngeal carcinoma and possibly associated with tumour metastasis
Authors:
- 2 July 2014
- journal article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 41 (9) , 5979-5988
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- BTG1 inhibits breast cancer cell growth through induction of cell cycle arrest and apoptosisOncology Reports, 2013
- In vitro cell migration and invasion assaysMutation Research - Reviews in Mutation Research, 2013
- Mitochondrial Biogenesis Drives Tumor Cell ProliferationThe American Journal of Pathology, 2011
- Oncogenes and Tumor Suppressor GenesCold Spring Harbor Perspectives in Biology, 2010
- The mammalian anti‐proliferative BTG/Tob protein familyJournal of Cellular Physiology, 2009
- Exploration of target molecules for prostate cancer gene therapyThe Prostate, 2007
- B cell translocation gene 1 contributes to antisense Bcl-2-mediated apoptosis in breast cancer cellsMolecular Cancer Therapeutics, 2006
- The gene PC3TIS21/BTG2, prototype member of the PC3/BTG/TOB family: Regulator in control of cell growth, differentiation, and DNA repair?Journal of Cellular Physiology, 2001
- BTG gene expression in the p53-dependent and -independent cellular response to DNA damageMolecular Carcinogenesis, 2000
- Identification of BTG2, an antiproliferative p53–dependent component of the DNA damage cellular response pathwayNature Genetics, 1996